RAPP
Rapport Therapeutics, Inc.
34.10$
-17.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Rapport Therapeutics, Inc. (RAPP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -41 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.4 | -10 | -18 | -16 | -16 | -14 | -20 | -25 | -17 | -25 | -13 | -41 | -97 | |
| 0.0 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 | 1.0 | |
| 0.9 | 1.0 | 1.5 | 2.4 | 3.2 | 3.2 | 4.0 | 4.4 | 4.7 | 5.7 | 7.0 | 7.2 | 25 | |
| 2.3 | 1.9 | -3.2 | -0.1 | 3.3 | 1.3 | -0.4 | -3.4 | 3.7 | 3.6 | -0.8 | 8.5 | 15 | |
| 0.1 | 1.4 | 1.1 | 1.0 | 0.1 | 0.2 | 0.3 | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 | 0.5 | |
| -0.1 | -79 | -42 | -107 | -53 | 32 | 21 | 23 | -57 | -174 | 38 | 26 | -168 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 85 | -0.1 | 64 | 159 | -1.4 | 0.0 | 0.0 | -0.1 | 271 | 0.3 | 0.5 | 1.4 | 273 | |
| 80 | -89 | 4.1 | 36 | -71 | 17 | 0.8 | -2.5 | 196 | -199 | 25 | -14 | 8.5 | |
| -5.5 | -12 | -19 | -17 | -17 | -15 | -21 | -25 | -18 | -25 | -13 | -42 | -97 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.